HeraMED Limited (FRA:1I4)
Germany
· Delayed Price · Currency is EUR 0.0225
-0.0010 (-4.26%)
At close: Dec 4, 2025
HeraMED Company Description
HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States.
It also provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a remote fetal heart rate monitoring solution.
The company has a collaboration agreement with Mayo Clinic for the development of its HeraCARE pregnancy management platform; and Broward Health for deployment of its HeraCARE to deliver care outcomes for pregnant mothers.
HeraMED Limited was founded in 2011 and is based in Hawthorn East, Australia.
HeraMED Limited
| Country | Australia |
| Founded | 2011 |
| Industry | Electromedical and Electrotherapeutic Apparatus |
| CEO | Anoushka Gungadin |
Contact Details
Address: 117 Camberwell Road Hawthorn East, 3123 Australia | |
| Phone | 61 2 7251 1888 |
| Website | hera-med.com |
Stock Details
| Ticker Symbol | 1I4 |
| Exchange | Frankfurt Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | AUD |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Anoushka Gungadin | Chief Executive Officer |
| Cameron Jones | Chief Financial Officer |
| Henry Jordan | Head of Investor Relations |